Project Grant HT94252410942
Award Date
9/15/24
Completion Date
9/14/26
Dollars Obligated
$634K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
This federal Project Grant award of $435,876.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2027, supports advanced biomedical research by Temple University to investigate KIF11, a novel therapeutic target for lymphedema. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative solutions to...
The U.S. Defense Health Agency awarded a $1,999,996 Project Grant to Temple University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to identify diagnostic biomarkers of cerebrovascular contributions to cognitive impairment in repeated blast concussion. This 4-year research project, running from June 2025 to May 2029, aims to transform healthcare for military service members, veterans, and the broader public by...
The federal Project Grant award of $1,585,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2029, supports advanced biomedical research at Temple University-Of The Commonwealth System Of Higher Education aimed at "TARGETING LYMPHATIC CHEMOKINE SIGNALING TO PROMOTE LYMPHANGIOGENESIS FOR THE TREATMENT OF LYMPHEDEMA". The grant funding will enable Temple...
The U.S. Defense Health Agency awarded a $700,788 Project Grant to The Institute For Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project to study the targeting of the nuclear necroptosis pathway in the pancreatic cancer microenvironment. As a prime grantee, The Institute For Cancer Research will conduct preclinical testing, biomarker analysis, and other specialized...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The Department of the Army Medical Command awarded a $1,188,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Temple University to support research aimed at identifying therapeutic peptide drugs for regenerating visual pathways. The award, effective September 15, 2024, will fund this initiative over a 3-year period through September 14, 2027. As a prominent public research university, Temple University has extensive experience conducting advanced...
Temple University-Of The Commonwealth System Of Higher Education received a $315,618 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 through May 31, 2025 examining the role of exosomes on the alveolar epithelium in idiopathic pulmonary fibrosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The U.S. Defense Health Agency awarded a $1,880,000 Project Grant to The Institute for Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project to study the SRPK1-AKT signaling axis in endometrial cancer. As a prime grantee, The Institute for Cancer Research will conduct preclinical testing and analysis to develop new approaches for cancer prevention and...
Temple University was awarded a $2.53 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into the role of TRAF6 in primary alveolar epithelial cell injury from September 2021 through September 2025. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical research, this project will...
The Temple University-Of The Commonwealth System Of Higher Education will research novel intracellular oncogenic functions of CTLA4 in melanoma under a $1.19 million Project Grant from the Department of the Army Medical Command. The grant was awarded on August 1, 2022 for a three-year period concluding on July 31, 2025. The research is being conducted under the Military Medical Research and Development program administered by the Department of the Army Medical Command. This program aims to...